The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Gubra’s once-weekly obesity candidate was tied to 3% weight loss during a six-week phase 1 trial, with a single injection ...

Obese or overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean percent changes in body weight from baseline of ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

With promising Phase 1 results in hand, Metsera hopes to develop a longer-lasting GLP-1 injection along with other types of ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

With the hope of enhancing wellness in North Platte, cousins and co-owners Jacque Stittle and Natasha Jarvis-Burch opened Elevate IVy.

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

Metabolism-targeting injections could pave the way for a new treatments, detection and prevention of bowel cancer ...

This class of medications, including both long-acting and short-acting formulations, plays a crucial role in managing ...

Drake vs. Metro Boomin The feud between Drake and Metro Boomin, which simmered in 2023, came to a head in 2024. The tension ...